Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
11
×
clinical trials
11
×
europe blog main
11
×
fda
11
×
life sciences
national blog main
europe top stories
boston blog main
national
national top stories
new york blog main
san francisco blog main
boston top stories
new york top stories
san francisco top stories
eli lilly
indiana blog main
indiana top stories
abbvie
boulder/denver blog main
boulder/denver top stories
cancer
detroit blog main
detroit top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
allergan
cancer immunotherapy
amgen
chronic kidney disease
covid-19
deals
What
drug
bio
fda
roundup
cancer
companies
days
ipo
medicine
medicines
new
approval
biotech
black
diamond
leading
life
market
marketing
nod
patients
research
science
street
therapeutics
treatment
wall
week
weight
wins
abbvie’s
acquisitions
adults
ahead
alkermes
allergan
alliance
amgen
amgen’s
announced
Language
unset
Current search:
fda
×
biotech
×
" europe blog main "
×
" clinical trials "
×
@xconomy.com
3 years ago
FDA Panel Vote Weighs in Favor of Alkermes Psyche Drug, With Caveats
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
3 years ago
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
4 years ago
FDA Rejects Boehringer Ingelheim, Eli Lilly Drug for Type 1 Diabetes
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines
@xconomy.com
4 years ago
Amgen’s Osteoporosis Drug Wins European Nod, With a Heart Warning